Cargando…
Trimethylamine N-oxide in atrial fibrillation progression
The human gut microbiome and its metabolite Trimethylamine N-oxide (TMAO) are sensitive to the human diet and are involved in the complex pathomechanisms that underpin diabetes, obesity, and cardiovascular diseases. A potential involvement of increased TMAO in atrial fibrillation (AF) manifestation...
Autores principales: | Büttner, Petra, Okun, Jürgen G., Hauke, Jana, Holzwirth, Erik, Obradovic, Danilo, Hindricks, Gerhard, Thiele, Holger, Kornej, Jelena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7452421/ https://www.ncbi.nlm.nih.gov/pubmed/32885030 http://dx.doi.org/10.1016/j.ijcha.2020.100554 |
Ejemplares similares
-
Anti-inflammatory HDL effects are impaired in atrial fibrillation
por: Holzwirth, Erik, et al.
Publicado: (2021) -
Arginine derivatives in atrial fibrillation progression phenotypes
por: Büttner, Petra, et al.
Publicado: (2020) -
Correction to: Arginine derivatives in atrial fibrillation progression phenotypes
por: Büttner, Petra, et al.
Publicado: (2021) -
Are the atrial natriuretic peptides a missing link predicting low‐voltage areas in atrial fibrillation? Introducing the novel biomarker‐based atrial fibrillation substrate prediction (ANP) score
por: Seewöster, Timm, et al.
Publicado: (2020) -
Genomic contributors to atrial electroanatomical remodeling and atrial fibrillation progression: Pathway enrichment analysis of GWAS data
por: Husser, Daniela, et al.
Publicado: (2016)